A Case Report of Allergic Bronchopulmonary Aspergillosis Treated with Homoeopathy

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is a fungal lung infection that primarily affects patients with bronchial asthma, cystic fibrosis, and those who are immunocompromised. Patients typically present with symptoms such as cough, dyspnea, pleuritic chest pain, and blood-stained sputum or hemoptysis, often with a history of uncontrolled asthma. This case report describes a 22-year-old female patient with ABPA and bronchial asthma, presenting with a two-year history of cough, dyspnea, and hemoptysis. The patient's condition improved successfully within six months of homoeopathic treatment using Phosphorus, with repetition as needed. The improvement was evaluated using the Asthma Quality of Life Questionnaire with standardized activities, revealing marked improvement in symptoms and quality of life after homoeopathic intervention.

Keywords

homoeopathy - bronchial asthma - allergic bronchopulmonary aspergillosis - dyspnoea

Note

The following case report presents clinical improvement primarily based on subjective parameters, such as patient-reported relief and changes in emotional and physical well-being. While such outcomes are valuable–especially in the context of individualized homeopathic care–readers are encouraged to interpret the findings within the limitations of non-objective measures and the absence of quantifiable biomarkers.

It is also noteworthy that Phosphorus 200C, a deep-acting constitutional remedy, was repeated more frequently than is typically recommended in classical homeopathic practice. This approach may raise questions regarding posology. However, the prescribing physician's clinical judgment was based on the patient's consistent responsiveness and the nature of the symptoms presented.

We publish such cases to contribute to ongoing debate around remedy repetition, case management, and the role of subjective outcomes in clinical decision-making. Readers are encouraged to reflect critically on the case while considering the broader spectrum of homeopathic prescribing principles.

Publikationsverlauf

Artikel online veröffentlicht:
17. April 2025

• References

• 1 Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT, Aggarwal AN. Allergic bronchopulmonary aspergillosis. Clin Chest Med 2022; 43 (01) 99-125
• 2 Davidson S. Davidson's Principles and Practice of Medicine. 18th ed. Elsevier Limited: 2006: 329-333
• 3 Agarwal R, Chakrabarti A. Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues. Future Microbiol 2013; 8 (11) 1463-1474
• 4 Prajapati S, Sharma M, Kumar A. et al. Antimicrobial activity of different homoeopathic drugs and their potencies against 'Aspergillus niger' In vitro. Indian J Res Homoeopathy 2019; 13 (03) 150-157
• 5 Reilly DT, Taylor MA, McSharry C, Aitchison T. Is homoeopathy a placebo response? Controlled trial of homoeopathic potency, with pollen in hayfever as model. Lancet 1986; 2 (8512) 881-886
• 6 Wiesenauer M, Häussler S, Gaus W. [Pollinosis therapy with Galphimia glauca]. Fortschr Med 1983; 101 (17) 811-814
• 7 Ullman Dana. Frass Michael. A Review of Homoeopathic Research in the Treatment of Respiratory Allergies. Alternative Medicine Review: A journal of Clinical Therapeutics. April 2010; 15 (01) 48-58
• 8 Hahnemann S. The Chronic Diseases Their Peculiar Nature and Their Homoeopathic Cure. New Delhi: B Jain publisher; 1995: 126-129
• 9 Allen HC. Keynotes & Characteristics Rearranged with Comparison of Some of the Leading Remedies of the Materia Medica with Bowel Nosodes. 8th ed. New Delhi: B Jain Publishers Pvt Ltd; 2016: 241-244
• 10 Boericke W. Boericke's New Manual of Homoeopathic Materia Medica with Repertory. 3rd revised & augmented edition based on 9th ed. New Delhi. B Jain Publishers Pvt Ltd; 2016: 507-511
• 11 Snen H, Kallel A, Blibech H. et al. Case report: allergic bronchopulmonary aspergillosis revealing asthma. Front Immunol 2021; 12: 695954